166 related articles for article (PubMed ID: 3023434)
1. Humoral immune deficiency in multiple myeloma patients due to compromised B-cell function.
Pilarski LM; Andrews EJ; Mant MJ; Ruether BA
J Clin Immunol; 1986 Nov; 6(6):491-501. PubMed ID: 3023434
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
[TBL] [Abstract][Full Text] [Related]
3. Specificity repertoire of lymphocytes from multiple myeloma patients. I. High frequency of B cells specific for idiotypic and F(ab')2-region determinants on immunoglobulin.
Pilarski LM; Piotrowska-Krezolak M; Gibney DJ; Winger L; Winger C; Mant MJ; Ruether BA
J Clin Immunol; 1985 Jul; 5(4):275-84. PubMed ID: 2995434
[TBL] [Abstract][Full Text] [Related]
4. Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels.
Pilarski LM; Ruether BA; Mant MJ
J Clin Invest; 1985 Jun; 75(6):2024-9. PubMed ID: 2989339
[TBL] [Abstract][Full Text] [Related]
5. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
[TBL] [Abstract][Full Text] [Related]
6. Studies on the pathogenesis of an immune defect in multiple myeloma.
Paglieroni T; MacKenzie MR
J Clin Invest; 1977 Jun; 59(6):1120-33. PubMed ID: 16939
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of immunodeficiency in patients with monoclonal gammopathy of undetermined significance and patients with untreated multiple myeloma.
Pilarski LM; Andrews EJ; Serra HM; Ruether BA; Mant MJ
Scand J Immunol; 1989 Feb; 29(2):217-28. PubMed ID: 2784225
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the specific IgM and IgG antibody response in humans induced by antigen (tetanus toxoid) or a polyclonal activator (EBV) in vitro.
Kozbor D; Roder JC
Int Arch Allergy Appl Immunol; 1983; 72(3):260-6. PubMed ID: 6311755
[TBL] [Abstract][Full Text] [Related]
9. IgG anti-tetanus toxoid antibody production induced by Epstein-Barr virus from B cells of human marrow transplant recipients.
Jin NR; Lum LG
Cell Immunol; 1986 Aug; 101(1):266-73. PubMed ID: 2427210
[TBL] [Abstract][Full Text] [Related]
10. Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
Kozbor D; Lagarde AE; Roder JC
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6651-5. PubMed ID: 6292911
[TBL] [Abstract][Full Text] [Related]
11. Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells.
Yarchoan R; Tosato G; Blaese RM; Simon RM; Nelson DL
J Exp Med; 1983 Jan; 157(1):1-14. PubMed ID: 6294212
[TBL] [Abstract][Full Text] [Related]
12. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
Lum LG; Culbertson NJ
J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
[TBL] [Abstract][Full Text] [Related]
13. EBV transformed B cell lines present to antigen specific T cell clones determinants different from those recognized by antibody in an HLA-DR linked restricted fashion.
Chu E; Umetsu D; Yunis E; Geha RS
Hum Immunol; 1983 Nov; 8(3):217-26. PubMed ID: 6196340
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of interleukin-4 induction and interferon-gamma inhibition of IgE secretion by Epstein-Barr virus-infected human peripheral blood B cells.
Thyphronitis G; Banchereau J; Heusser C; Tsokos GC; Levine AD; Finkelman FD
Cell Immunol; 1991 Apr; 133(2):408-19. PubMed ID: 1849800
[TBL] [Abstract][Full Text] [Related]
15. In vitro human antibody production to the Haemophilus influenzae type b capsular polysaccharide.
Munoz JL; Insel RA
J Immunol; 1987 Sep; 139(6):2026-31. PubMed ID: 3040862
[TBL] [Abstract][Full Text] [Related]
16. Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production.
Stein LD; Sigal NH
Cell Immunol; 1983 Jul; 79(2):309-19. PubMed ID: 6307533
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.
Kobold S; Luetkens T; Bartels BM; Cao Y; Hildebrandt Y; Sezer O; Reinhard H; Templin J; Bartels K; Lajmi N; Haag F; Bokemeyer C; Kröger N; Atanackovic D
Clin Dev Immunol; 2012; 2012():134081. PubMed ID: 22481961
[TBL] [Abstract][Full Text] [Related]
18. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
19. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
20. Activation of human B lymphocytes: frequency of antigen-specific B cells triggered by alloreactive or by antigen-specific T cell clones.
Lanzavecchia A; Parodi B; Celada F
Eur J Immunol; 1983 Sep; 13(9):733-8. PubMed ID: 6604634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
